Sugi Predict

Sugi Predict / Compounds / SCHEMBL22818447

SCHEMBL22818447

SCHEMBL22818447

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3ccc(-c4cccc5oc6c7ccccc7c(-c7ccccc7)cc6c45)cc3)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.41
▸ CDC14B O60729 2/20 0.34
▸ CDC14A Q9UNH5 2/20 0.34
▸ PLA2G2A P14555 4/20 0.33
▸ PLA2G4A P47712 4/20 0.33
▸ CYP1B1 Q16678 2/20 0.33
▸ GGPS1 O95749 1/20 0.33
▸ CYP1A1 P04798 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ PIM1 P11309 1/20 0.32
▸ CSNK2A2 P19784 1/20 0.32
▸ CSNK2B P67870 1/20 0.32
▸ PIM3 Q86V86 1/20 0.32
▸ PIM2 Q9P1W9 1/20 0.32
▸ PRKDC P78527 2/20 0.32
▸ TNKS O95271 2/20 0.32
▸ CDK1 P06493 1/20 0.32
▸ CCNB1 P14635 1/20 0.32
▸ GSK3B P49841 1/20 0.32
▸ CDK5 Q00535 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22818444 1.00 ALOX5 (0.41) ALOX5CDC14BCDC14APLA2G2APLA2G4A
SCHEMBL22818144 0.99 ALOX5 (0.40) ALOX5CDC14BCDC14APLA2G2APLA2G4A
SCHEMBL22818156 0.97 ALOX5 (0.41) ALOX5CDC14BCDC14APLA2G2APLA2G4A
SCHEMBL22818443 0.95 ALOX5 (0.40) ALOX5CDC14BCDC14APLA2G2APLA2G4A
SCHEMBL22817749 0.95 ALOX5 (0.40) ALOX5CDC14BCDC14APLA2G2APLA2G4A
SCHEMBL22818433 0.95 ALOX5 (0.40) ALOX5CDC14BCDC14APLA2G2APLA2G4A
SCHEMBL22818342 0.95 ALOX5 (0.40) ALOX5CDC14BCDC14APLA2G2APLA2G4A
SCHEMBL22817867 0.95 ALOX5 (0.40) ALOX5CDC14BCDC14APLA2G2APLA2G4A
SCHEMBL22817780 0.95 ALOX5 (0.39) ALOX5CDC14BCDC14APLA2G2APLA2G4A
SCHEMBL22818335 0.94 ALOX5 (0.40) ALOX5CDC14BCDC14APLA2G2APLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
WO-2023149718-A1 ORGANIC LIGHT-EMITTING ELEMENT INCLUDING HETEROCYCLIC COMPOUND, COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING ELEMENT, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING ELEMENT 엘티소재주식회사 2023-08-10 — — WO disclosed
WO-2023096225-A1 HETEROCYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER, COMPRISING SAME 엘티소재주식회사 2023-06-01 — — WO disclosed
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LT MATERIALS CO., LTD. (KR) 2020-12-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same CRY1, CRY2, PER2 ALOX5 1385/4885CDC14B 589/4885CDC14A 484/4885
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CRY1, CRY2, PER2 ALOX5 1385/4885CDC14B 589/4885CDC14A 484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.